Login
Adgang til udbud
Kontakt os
63 13 37 00
Danmark
Danmark
Deutschland
Eesti
Latvija
Lietuva
Norge
Polska
Russia
Suomi
Sverige
World
UK & Ireland
USA
Nederland
България
Danmark
Danmark
Deutschland
Eesti
Latvija
Lietuva
Norge
Polska
Russia
Suomi
Sverige
World
UK & Ireland
USA
Nederland
България
Kontakt os
Login
Toggle navigation
Support
Mercell Danmark Kundeservice
Mercell CTM Dansk Kundeservice (tidligere EU-Supply)
Mercell Udbudsvagten Kundeservice
Mercell Ethics Kundeservice
Mercell Customer Service - TrueLink
Mercell Customer Service - Comcare
Mercell Customer Service DK (P2P)
Mercell Source-to-Contract Danmark
Blog
Søg udbud
Procurement
Kontraktstyring
Indkøbsløsning
E-fakturering
Indkøbsanalyse
Invoice & Match
Procurement løsninger
Udbudsportaler
Udbudsportal
ETHICS' Udbudsportal
EU-Supplys Udbudsportal
Det siger vores kunder
Source-to-contract
Overvågningsværktøjer
UdbudsOvervågning
ReferatOvervågning
UdbudsPlan
KonkurrentOvervågning
Hjemmesiden
Udbud
REQUEST FOR INFORMATION: Diagnostic NIPT testing process of HUSLAB
Information
Bekendtgørelsestype
 
Type
Procedure
 
Forventet opstart af tilbudsprocessen
Forventet slutdato for tilbudsprocessen
Offentliggørelse
30-11-2020 16:08 (GMT+01:00)
Tidsfrist
24-01-2021 15:00 (GMT+01:00)
Spørgefrist
Anbefalet dokumentfrist
Accepterer alternative tilbud
Nej
Accepterer alternative tilbud
Nej
Indkøber
Ordregiver
HUS Logistics
HUS Logistics
Afdeling
Kontakt
Mervi Ahokannas
Addresse
PL 441 (Uutistie 5, 01770 Vantaa)
00029
HUS
Finland
CVR nr
1567535-0
Hjemmeside
www.hus.fi
Tidsfristen er overskredet
Kort beskrivelse
THIS IS NOT A CONTRACT NOTICE NOR A CALL FOR TENDER.
This is not a call for tenders and does not obligate the Acquisition Unit of the Joint Authority of the Helsinki and Uusimaa Hospital District for any actions. The responses to this information request do not obligate the acquisition unit to any material of service acquisitions.
HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is a SFS-EN ISO 15189:2013 accredited laboratory providing diagnostic genetic testing services to all patients at Helsinki University Hospital area. The services include analysis of both constitutional samples and malignancies. The laboratory provides sequencing services mainly using local HUSLAB sequencing capacity (Illumina NovaSeq 6000, Ion Torrent S5 and Ion Torrent Proton equipment).
Currently annual number of NIPT tests performed through HUSLAB is 600 - 800. Using current patient selection criteria the estimated testing volume would be 10 - 20 samples per week. No major changes in test volume is expected unless the criteria of patient selection is
altered.
Due to discontinuation of the reagent kit used in in house analysis pipeline the laboratory has terminated diagnostic NIPT testing and will find a replacement solution.
This request for information is released for preliminary evaluation and market research for potential replacement solutions for diagnostic NIPT testing process of HUSLAB. The main objects of this information request are:
1) to obtain information about available alternative reagents, reagent kits, consumables and software for continuation of performing preferably IVD-CE certified NIPT testing using local HUSLAB sequencing capacity.
2) to obtain information about available CE-IVD certified low-to-medium throughput NIPT testing solutions (NGS or other technologies) using other than local NGS capacity.
The response to this request information should include description of the analytical pipeline offered. An estimation of the cost of verification samples in order to verify the sensitivity, specificity and reproducibility of the offered analysis pipeline should also be included.
The information presented in this document and during the information process is preliminary and indicative. HUS does not guarantee to carry out the procurement or a specific method of implementation. The suppliers interested in the procurement are not bound to submit a
tender later on in the possible procurement process. HUS does not pay allowances or compensation for participation in this request for information -process.
Submitting answers:
The supplier should preferably submit an answer to the request for information electronically via Tarjouspalvelu.fi by 4 pm (Finnish time) on 24th of January 2021. Responses from suppliers will be treated confidentially. This request for information is not binding on the Helsinki and Uusimaa Hospital District.
THIS IS NOT A CONTRACT NOTICE NOR A CALL FOR TENDER.
This is not a call for tenders and does not obligate the Acquisition Unit of the Joint Authority of the Helsinki and Uusimaa Hospital District for any actions. The responses to this information request do not obligate the acquisition unit to any material of service acquisitions.
HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is a SFS-EN ISO 15189:2013 accredited laboratory providing diagnostic genetic testing services to all patients at Helsinki University Hospital area. The services include analysis of both constitutional samples and malignancies. The laboratory provides sequencing services mainly using local HUSLAB sequencing capacity (Illumina NovaSeq 6000, Ion Torrent S5 and Ion Torrent Proton equipment).
Currently annual number of NIPT tests performed through HUSLAB is 600 - 800. Using current patient selection criteria the estimated testing volume would be 10 - 20 samples per week. No major changes in test volume is expected unless the criteria of patient selection is
altered.
Due to discontinuation of the reagent kit used in in house analysis pipeline the laboratory has terminated diagnostic NIPT testing and will find a replacement solution.
This request for information is released for preliminary evaluation and market research for potential replacement solutions for diagnostic NIPT testing process of HUSLAB. The main objects of this information request are:
1) to obtain information about available alternative reagents, reagent kits, consumables and software for continuation of performing preferably IVD-CE certified NIPT testing using local HUSLAB sequencing capacity.
2) to obtain information about available CE-IVD certified low-to-medium throughput NIPT testing solutions (NGS or other technologies) using other than local NGS capacity.
The response to this request information should include description of the analytical pipeline offered. An estimation of the cost of verification samples in order to verify the sensitivity, specificity and reproducibility of the offered analysis pipeline should also be included.
The information presented in this document and during the information process is preliminary and indicative. HUS does not guarantee to carry out the procurement or a specific method of implementation. The suppliers interested in the procurement are not bound to submit a
tender later on in the possible procurement process. HUS does not pay allowances or compensation for participation in this request for information -process.
Submitting answers:
The supplier should preferably submit an answer to the request for information electronically via Tarjouspalvelu.fi by 4 pm (Finnish time) on 24th of January 2021. Responses from suppliers will be treated confidentially. This request for information is not binding on the Helsinki and Uusimaa Hospital District.
Filer
Navn
Størrelse
Diagnostic NIPT testing process of HUSLAB.pdf
92 KB
Mercell A/S
En del af Mercell, en af Europas ledende aktører inden for formidling af information mellem indkøber og leverandør på det professionelle marked. CVR nr. 25698851
Virksomhedsprofil
Om os
Historie og vision
Job
Samarbejdspartnere
ISO 27001
Blog
Produkter
Mercells Udbudsportal
ETHICS' Udbudsportal
EU-Supplys Udbudsportal
Overvågningsværktøjer
Procurement
Kontakt
Klik her for at gå til support
+45 63 13 37 00
Mercell A/S
|
B!NGS
Vesterbrogade 149
,
1620
København V
,
Danmark
Privatlivspolitik
|
Cookies
|
Vilkår og betingelser
|
Kontakt os
|
Login